J. Kult

发表

Suitability of non-glucose-carbohydrates for parenteral nutrition

B. L. Bauer, W. Dick, A. Heidland, 1975, European journal of intensive care medicine.

Long-term effects of essential amino acids supplementation in patients on regular dialysis treatment.

A. Heidland, J. Kult, 1975, Clinical nephrology.

Changing Emphasis in Modern Hemodialysis Therapies: Cost-Effectiveness of Delivering Higher Doses of Dialysis

J. Kult, E. Stapf, 2007, The International journal of artificial organs.

Evaluation of essential amino acids and keto acids in uremic patients on low-protein diet.

E. Heidbreder, A. Heidland, J. Kult, 1978, The American journal of clinical nutrition.

Tolerability and Efficacy of Multidose Epoetin Beta (Reco-Pen®) for Subcutaneous Administration in Patients with Anemia due to Renal Failure

W. Kleophas, J. Kult, W. Kreusser, 2003, Kidney and Blood Pressure Research.

Beta2-Mikroglobulin im Serum — ein Parameter des Glomerulumfiltrates*

A. Heidland, J. Kult, A. Röckel, 1974 .

Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.

J. Kult, M. Glocke, W. Häcker, 1988, Arzneimittel-Forschung.

[The pros and cons of haemoperfusion (author's transl)].

A. Heidland, H. Hennemann, Heinrich Brunswig, 1977, Klinische Wochenschrift.

High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure.

J. Kult, W. Boesken, 1997, Clinical Nephrology.